Beijing Tiantan Biological Products Corp Ltd Financial Flexibility Index
Beijing Tiantan Biological Products Corp Ltd financial flexibility index. Beijing Tiantan Biological Products Corp Ltd (600161) has a Financial Flexibility Index of 0.28x as of September 2025. Free cash flow of CN¥443.87 Million (operating CF CN¥318.80 Million minus capex CN¥125.07 Million) represents 0% of total liabilities (CN¥1.60 Billion). Explore Beijing Tiantan Biological Products Corp capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Beijing Tiantan Biological Products Corp Ltd (1998–2024)
Financial flexibility index of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. Historical Financial Flexibility Index trend for Beijing Tiantan Biological Products Corp Ltd across 27 annual periods. Check 600161 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Beijing Tiantan Biological Products Corp Ltd Financial Flexibility Index by Year (1998–2024)
Beijing Tiantan Biological Products Corp Ltd financial flexibility index by year from 1998 to 2024. Year-by-year free cash flow to debt coverage for Beijing Tiantan Biological Products Corp Ltd. For the full cash flow conversion analysis, see how efficiently does Beijing Tiantan Biological Products Corp generate cash.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | CN¥1.89 Billion | CN¥819.78 Million | CN¥1.34 Billion | ▼ -41.7% |
| 2023 | 2.42x | CN¥3.47 Billion | CN¥2.39 Billion | CN¥1.43 Billion | ▲ +54.7% |
| 2022 | 1.57x | CN¥2.48 Billion | CN¥1.13 Billion | CN¥1.58 Billion | ▼ -2.9% |
| 2021 | 1.61x | CN¥2.11 Billion | CN¥980.35 Million | CN¥1.31 Billion | ▲ +85.6% |
| 2020 | 0.87x | CN¥1.31 Billion | CN¥702.11 Million | CN¥1.51 Billion | ▼ -15.5% |
| 2019 | 1.03x | CN¥1.17 Billion | CN¥642.47 Million | CN¥1.14 Billion | ▼ -23.8% |
| 2018 | 1.35x | CN¥971.82 Million | CN¥677.92 Million | CN¥720.19 Million | ▲ +78.8% |
| 2017 | 0.75x | CN¥363.26 Million | CN¥218.39 Million | CN¥481.46 Million | ▲ +295.4% |
| 2016 | 0.19x | CN¥637.77 Million | CN¥428.37 Million | CN¥3.34 Billion | ▼ -16.3% |
| 2015 | 0.23x | CN¥773.83 Million | CN¥473.26 Million | CN¥3.40 Billion | ▼ -8.1% |
| 2014 | 0.25x | CN¥942.11 Million | CN¥477.95 Million | CN¥3.80 Billion | ▼ -23.0% |
| 2013 | 0.32x | CN¥1.11 Billion | CN¥566.43 Million | CN¥3.46 Billion | ▼ -1.4% |
| 2012 | 0.33x | CN¥989.88 Million | CN¥432.00 Million | CN¥3.03 Billion | ▼ -45.8% |
| 2011 | 0.60x | CN¥1.07 Billion | CN¥353.15 Million | CN¥1.78 Billion | ▲ +63.2% |
| 2010 | 0.37x | CN¥482.39 Million | CN¥184.85 Million | CN¥1.31 Billion | ▼ -30.0% |
| 2009 | 0.53x | CN¥639.39 Million | CN¥448.23 Million | CN¥1.21 Billion | ▼ -45.7% |
| 2008 | 0.97x | CN¥426.70 Million | CN¥276.39 Million | CN¥439.35 Million | ▲ +63.1% |
| 2007 | 0.60x | CN¥219.95 Million | CN¥153.55 Million | CN¥369.34 Million | ▼ -6.1% |
| 2006 | 0.63x | CN¥225.86 Million | CN¥154.36 Million | CN¥356.20 Million | ▼ -33.6% |
| 2005 | 0.95x | CN¥171.47 Million | CN¥131.69 Million | CN¥179.67 Million | ▼ -38.8% |
| 2004 | 1.56x | CN¥196.00 Million | CN¥110.11 Million | CN¥125.70 Million | ▲ +62.3% |
| 2003 | 0.96x | CN¥152.95 Million | CN¥62.93 Million | CN¥159.24 Million | ▲ +73.8% |
| 2002 | 0.55x | CN¥119.21 Million | CN¥84.38 Million | CN¥215.73 Million | ▲ +0.4% |
| 2001 | 0.55x | CN¥95.58 Million | CN¥46.49 Million | CN¥173.64 Million | ▼ -0.2% |
| 2000 | 0.55x | CN¥91.94 Million | CN¥47.90 Million | CN¥166.77 Million | ▲ +2.6% |
| 1999 | 0.54x | CN¥85.92 Million | CN¥42.58 Million | CN¥159.88 Million | ▼ -25.6% |
| 1998 | 0.72x | CN¥81.32 Million | CN¥23.71 Million | CN¥112.54 Million | — |